General
Preferred name
ETIDOCAINE
Synonyms
W-19053 ()
Duranest ()
W19053 ()
W 19053 ()
Etidocaine ()
ETIDOCAINE HYDROCHLORIDE ()
Etidocaine (hydrochloride) ()
EDC (hydrochloride) ()
Etidocaina ()
W-19053 [AS HYDROCHLORIDE] ()
W-19053 FREE BASE ()
Etidocaine HCl ()
Duranest hydrochloride ()
Etidocaine hydrochloride component of duranest ()
P&D ID
PD009421
CAS
36637-18-0
60108-68-1
36637-19-1
Tags
available
drug
Approved by
FDA
First approval
1976
Drug Status
approved
withdrawn
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 275
DESCRIPTION Etidocaine (hydrochloride) is a long aminoamide local agent that can suppress or relieve pain[1].
PRICE 269
DESCRIPTION Etidocaine is an amino acidamide that acts as a local anesthetic with fast onset and long-acting properties. (TargetMol Bioactive Compound Library)
DESCRIPTION Etidocaine Hydrochloride (W19053) is a long-acting anesthetic and a blocker of the voltage-gated sodium channel. (TargetMol Bioactive Compound Library)
Compound Sets
14
ChEMBL Approved Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
Withdrawn 2.0
External IDs
47
Properties
(calculated by RDKit )
Molecular Weight
276.22
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
1
Aromatic Ring Count
1
cLogP
3.75
TPSA
32.34
Fraction CSP3
0.59
Chiral centers
1.0
Largest ring
6.0
QED
0.82
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Voltage-gated sodium channel
Sodium Channel
ATC
N01BB07
Pathway
Membrane Transporter/Ion Channel
Source data